Global Anti-inflammatory Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

According to APO Research, The global Anti-inflammatory Therapeutics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti-inflammatory Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Anti-inflammatory Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Anti-inflammatory Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Anti-inflammatory Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Anti-inflammatory Therapeutics include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck and Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Anti-inflammatory Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Anti-inflammatory Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Anti-inflammatory Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-inflammatory Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Anti-inflammatory Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Anti-inflammatory Therapeutics revenue, projected growth trends, production technology, application and end-user industry.


Anti-inflammatory Therapeutics Segment by Company

AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA

Anti-inflammatory Therapeutics Segment by Type

Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others

Anti-inflammatory Therapeutics Segment by Application

Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others

Anti-inflammatory Therapeutics Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Anti-inflammatory Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-inflammatory Therapeutics industry.
Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-inflammatory Therapeuticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Global Market Growth Prospects
1.5 Global Anti-inflammatory Therapeutics Growth Trends by Region
1.5.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Anti-inflammatory Therapeutics Market Size by Region (2020-2025)
1.5.3 Anti-inflammatory Therapeutics Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Anti-inflammatory Therapeutics Market Dynamics
2.1 Anti-inflammatory Therapeutics Industry Trends
2.2 Anti-inflammatory Therapeutics Industry Drivers
2.3 Anti-inflammatory Therapeutics Industry Opportunities and Challenges
2.4 Anti-inflammatory Therapeutics Industry Restraints
3 Competitive Landscape by Company
3.1 Global Anti-inflammatory Therapeutics Revenue by Company (2020-2025)
3.2 Global Anti-inflammatory Therapeutics Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Anti-inflammatory Therapeutics Key Company Head office and Area Served
3.4 Global Anti-inflammatory Therapeutics Company, Product Type & Application
3.5 Global Anti-inflammatory Therapeutics Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Anti-inflammatory Therapeutics Market CR5 and HHI
3.6.2 Global Top 5 and 10 Anti-inflammatory Therapeutics Players Market Share by Revenue in 2024
3.6.3 2024 Anti-inflammatory Therapeutics Tier 1, Tier 2, and Tier 3
4 Anti-inflammatory Therapeutics Market by Type
4.1 Global Anti-inflammatory Therapeutics Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Anti-inflammatory Therapeutics Market Size by Type (2020-2031)
4.3 Global Anti-inflammatory Therapeutics Market Size Share by Type (2020-2031)
5 Anti-inflammatory Therapeutics Market by Application
5.1 Global Anti-inflammatory Therapeutics Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Anti-inflammatory Therapeutics Market Size by Application (2020-2031)
5.3 Global Anti-inflammatory Therapeutics Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 AbbVie
6.1.1 AbbVie Comapny Information
6.1.2 AbbVie Business Overview
6.1.3 AbbVie Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 AbbVie Anti-inflammatory Therapeutics Product Portfolio
6.1.5 AbbVie Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Comapny Information
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio
6.2.5 Johnson & Johnson Recent Developments
6.3 Amgen Inc
6.3.1 Amgen Inc Comapny Information
6.3.2 Amgen Inc Business Overview
6.3.3 Amgen Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Amgen Inc Anti-inflammatory Therapeutics Product Portfolio
6.3.5 Amgen Inc Recent Developments
6.4 AstraZeneca PLC
6.4.1 AstraZeneca PLC Comapny Information
6.4.2 AstraZeneca PLC Business Overview
6.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio
6.4.5 AstraZeneca PLC Recent Developments
6.5 Pfizer, Inc
6.5.1 Pfizer, Inc Comapny Information
6.5.2 Pfizer, Inc Business Overview
6.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio
6.5.5 Pfizer, Inc Recent Developments
6.6 Novartis
6.6.1 Novartis Comapny Information
6.6.2 Novartis Business Overview
6.6.3 Novartis Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Novartis Anti-inflammatory Therapeutics Product Portfolio
6.6.5 Novartis Recent Developments
6.7 Roche
6.7.1 Roche Comapny Information
6.7.2 Roche Business Overview
6.7.3 Roche Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 Roche Anti-inflammatory Therapeutics Product Portfolio
6.7.5 Roche Recent Developments
6.8 Merck
6.8.1 Merck Comapny Information
6.8.2 Merck Business Overview
6.8.3 Merck Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Merck Anti-inflammatory Therapeutics Product Portfolio
6.8.5 Merck Recent Developments
6.9 Sanofi
6.9.1 Sanofi Comapny Information
6.9.2 Sanofi Business Overview
6.9.3 Sanofi Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 Sanofi Anti-inflammatory Therapeutics Product Portfolio
6.9.5 Sanofi Recent Developments
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Comapny Information
6.10.2 GlaxoSmithKline Business Overview
6.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments
6.11 Sun Pharmaceutical Industries Ltd
6.11.1 Sun Pharmaceutical Industries Ltd Comapny Information
6.11.2 Sun Pharmaceutical Industries Ltd Business Overview
6.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio
6.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
6.12 TEVA
6.12.1 TEVA Comapny Information
6.12.2 TEVA Business Overview
6.12.3 TEVA Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.12.4 TEVA Anti-inflammatory Therapeutics Product Portfolio
6.12.5 TEVA Recent Developments
7 North America
7.1 North America Anti-inflammatory Therapeutics Market Size (2020-2031)
7.2 North America Anti-inflammatory Therapeutics Market Size by Type
7.2.1 North America Anti-inflammatory Therapeutics Market Size by Type (2020-2025)
7.2.2 North America Anti-inflammatory Therapeutics Market Size by Type (2026-2031)
7.2.3 North America Anti-inflammatory Therapeutics Market Share by Type (2020-2031)
7.3 North America Anti-inflammatory Therapeutics Market Size by Application
7.3.1 North America Anti-inflammatory Therapeutics Market Size by Application (2020-2025)
7.3.2 North America Anti-inflammatory Therapeutics Market Size by Application (2026-2031)
7.3.3 North America Anti-inflammatory Therapeutics Market Share by Application (2020-2031)
7.4 North America Anti-inflammatory Therapeutics Market Size by Country
7.4.1 North America Anti-inflammatory Therapeutics Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
7.4.3 North America Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
7.4.4 North America Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Anti-inflammatory Therapeutics Market Size (2020-2031)
8.2 Europe Anti-inflammatory Therapeutics Market Size by Type
8.2.1 Europe Anti-inflammatory Therapeutics Market Size by Type (2020-2025)
8.2.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2026-2031)
8.2.3 Europe Anti-inflammatory Therapeutics Market Share by Type (2020-2031)
8.3 Europe Anti-inflammatory Therapeutics Market Size by Application
8.3.1 Europe Anti-inflammatory Therapeutics Market Size by Application (2020-2025)
8.3.2 Europe Anti-inflammatory Therapeutics Market Size by Application (2026-2031)
8.3.3 Europe Anti-inflammatory Therapeutics Market Share by Application (2020-2031)
8.4 Europe Anti-inflammatory Therapeutics Market Size by Country
8.4.1 Europe Anti-inflammatory Therapeutics Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
8.4.3 Europe Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
8.4.4 Europe Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Anti-inflammatory Therapeutics Market Size (2020-2031)
9.2 China Anti-inflammatory Therapeutics Market Size by Type
9.2.1 China Anti-inflammatory Therapeutics Market Size by Type (2020-2025)
9.2.2 China Anti-inflammatory Therapeutics Market Size by Type (2026-2031)
9.2.3 China Anti-inflammatory Therapeutics Market Share by Type (2020-2031)
9.3 China Anti-inflammatory Therapeutics Market Size by Application
9.3.1 China Anti-inflammatory Therapeutics Market Size by Application (2020-2025)
9.3.2 China Anti-inflammatory Therapeutics Market Size by Application (2026-2031)
9.3.3 China Anti-inflammatory Therapeutics Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Anti-inflammatory Therapeutics Market Size (2020-2031)
10.2 Asia Anti-inflammatory Therapeutics Market Size by Type
10.2.1 Asia Anti-inflammatory Therapeutics Market Size by Type (2020-2025)
10.2.2 Asia Anti-inflammatory Therapeutics Market Size by Type (2026-2031)
10.2.3 Asia Anti-inflammatory Therapeutics Market Share by Type (2020-2031)
10.3 Asia Anti-inflammatory Therapeutics Market Size by Application
10.3.1 Asia Anti-inflammatory Therapeutics Market Size by Application (2020-2025)
10.3.2 Asia Anti-inflammatory Therapeutics Market Size by Application (2026-2031)
10.3.3 Asia Anti-inflammatory Therapeutics Market Share by Application (2020-2031)
10.4 Asia Anti-inflammatory Therapeutics Market Size by Country
10.4.1 Asia Anti-inflammatory Therapeutics Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
10.4.3 Asia Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
10.4.4 Asia Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size (2020-2031)
11.2 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type
11.2.1 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application
11.3.1 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
11.4.1 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings